OWP
AXDX

Obermeyer Wealth Partners’s Accelerate Diagnostics AXDX Stock Holding History

Obermeyer Wealth Partners’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,126
Closed -$3.46M – 123
2019
Q2 		$3.46M Hold
15,126
– – 0.31% 37
2019
Q1 		$3.18M Sell
15,126
-66
-0.4% -$12.4K 0.3% 37
2018
Q4 		$1.75M Sell
15,192
-1,911
-11% -$283K 0.18% 42
2018
Q3 		$3.92M Buy
17,103
+100
+0.6% +$22.1K 0.33% 34
2018
Q2 		$3.79M Hold
17,003
– – 0.34% 34
2018
Q1 		$3.88M Sell
17,003
-4,440
-21% -$1.17M 0.35% 33
2017
Q4 		$5.62M Buy
21,443
+30
+0.1% +$7.03K 0.49% 35
2017
Q3 		$4.81M Buy
21,413
+76
+0.4% +$18.7K 0.42% 37
2017
Q2 		$5.84M Buy
21,337
+66
+0.3% +$17.9K 0.52% 37
2017
Q1 		$5.15M Hold
21,271
– – 0.47% 36
2016
Q4 		$4.41M Hold
21,271
– – 0.42% 36
2016
Q3 		$5.8M Sell
21,271
-6,384
-23% -$1.41M 0.56% 35
2016
Q2 		$3.98M Hold
27,655
– – 0.4% 37
2016
Q1 		$3.97M Hold
27,655
– – 0.37% 36
2015
Q4 		$5.94M Hold
27,655
– – 0.54% 33
2015
Q3 		$4.47M Hold
27,655
– – 0.47% 35
2015
Q2 		$7.14M Sell
27,655
-150
-0.5% -$35.8K 0.61% 39
2015
Q1 		$6.26M Buy
27,805
+150
+0.5% +$31.3K 0.51% 53
2014
Q4 		$5.31M Buy
+27,655
New +$5.92M 0.48% 53

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Obermeyer Wealth Partners's AXDX Position: Q3 2019 in Review

Obermeyer Wealth Partners sold out of Accelerate Diagnostics (AXDX) in Q3 2019, closing a stake of 15,126 shares — an estimated $3.46M sold.

Obermeyer Wealth Partners first reported a position in AXDX in Q4 2014 and held it in 19 quarters. The position peaked at $7.14M in Q2 2015. 113 funds tracked by Wall St. Rank hold AXDX as of Q3 2019.

  • Obermeyer Wealth Partners reported no remaining Accelerate Diagnostics position as of Q3 2019 after selling out during the quarter.
  • Obermeyer Wealth Partners sold 15,126 Accelerate Diagnostics shares in Q3 2019, an estimated $3.46M.
  • Obermeyer Wealth Partners first reported a position in Accelerate Diagnostics in Q4 2014 and held it in 19 quarters.
  • Obermeyer Wealth Partners's Accelerate Diagnostics position peaked at $7.14M in Q2 2015.
  • 113 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2019.

Based on Obermeyer Wealth Partners's 13F filing for Q3 2019, filed 6 Nov 2019.